Metabolic tumor parameters complement clinicopathological factors in prognosticating advanced stage Hodgkin Lymphoma.

Mohite, Ashish; Rangarajan, Venkatesh; Goda, Jayant; Chugh, Swati; Agrawal, Archi; Sengar, Manju

Mohite, Ashish; Rangarajan, Venkatesh; Goda, Jayant; Chugh, Swati; Agrawal, Archi; Sengar, Manju.

Afiliación

Mohite A; Department of Nuclear medicine and Molecular Imaging, Tata Memorial Centre, Mumbai Maharashtra, India.
Rangarajan V; Homi Bhabha National Institute, Anushaktinagar, Mumbai, Maharashtra, India.
Goda J; Department of Nuclear medicine and Molecular Imaging, Tata Memorial Centre, Mumbai Maharashtra, India.
Chugh S; Homi Bhabha National Institute, Anushaktinagar, Mumbai, Maharashtra, India.
Agrawal A; Department of Radiation Oncology, Tata Memorial Centre, Mumbai Maharashtra, India.
Sengar M; Homi Bhabha National Institute, Anushaktinagar, Mumbai, Maharashtra, India.

Asia Ocean J Nucl Med Biol ; 11(2): 111-121, 2023.

Article en En | MEDLINE | ID: mdl-37324230

Palabras clave

18F-FDG PET/ CT; Advanced Hodgkin's lymphoma; Clinicopathological parameters; Event free survival; Metabolic tumor parameters

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Asia Ocean J Nucl Med Biol Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google